$USAQ Jun 29, 2021 (GLOBE NEWSWIRE via COMTEX) --
Post# of 9163
(Total Views: 97)
Posted On: 06/29/2021 8:03:30 AM
$USAQ Jun 29, 2021 (GLOBE NEWSWIRE via COMTEX) -- -Continued Momentum Expanding Independent Care Practitioner Network-
West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced it has entered into a distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd(R) allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO's member roster, the roll out will be done in stages so as to ensure adequate training and staff support.
"Today's announcement is further evidence of our continued progress and momentum as we expand our independent medical provider practice network. The growing interest in AllergiEnd(R)'s allergy diagnostic services and allergen immunotherapy products reflects the attractiveness of our value-based tools to proactively address chronic disease, provide preventive care as well as enable the broad market of general practitioner physicians to broaden their practices and revenue base," said Troy Grogan, CEO of USA Equities Corp.
West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based healthcare solutions and physician-directed digital medicine, today announced it has entered into a distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd(R) allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO's member roster, the roll out will be done in stages so as to ensure adequate training and staff support.
"Today's announcement is further evidence of our continued progress and momentum as we expand our independent medical provider practice network. The growing interest in AllergiEnd(R)'s allergy diagnostic services and allergen immunotherapy products reflects the attractiveness of our value-based tools to proactively address chronic disease, provide preventive care as well as enable the broad market of general practitioner physicians to broaden their practices and revenue base," said Troy Grogan, CEO of USA Equities Corp.
(0)
(0)Scroll down for more posts ▼